The urology community is mourning the death of Joseph W. Segura,MD, who died Tuesday, May 23 after a battle with mesothelioma.
The urology community is mourning the death of Joseph W. Segura, MD, who died Tuesday, May 23 after a battle with mesothelioma. Dr. Segura was best known as a leader in the minimally invasive management of kidney stone disease, and his clinical research set the standards in the field.
"Segura was an innovator in developing endoscopic techniques, using small incisions," Glenn Preminger, MD, of Duke University Medical Center in Durham, NC, told the Washington Post. "He was considered the father of the field."
Dr. Segura completed his residency in urology at the Mayo Clinic, Rochester, MN, where he remained for his entire career, and in 1983 was named Carl Rosen Professor of Urology. He held leadership positions in several national and international organizations, including secretary-elect of AUA, president of the International Society of Urologic Endoscopy, and president of the Minnesota Chapter of the American College of Surgeons. He served as general chairman of the 8th World Congress on Endourology and Shock Wave Lithotripsy.
Dr. Segura was also the recipient of many awards, including the AUA Distinguished Service Award, the Mayo Clinic Distinguished Clinician’s Award, Honorary Fellowship in the Royal College of Surgeons of Edinburgh, and the Karl Storz Lifetime Achievement Award from the Endourological Society.
He is survived by his five daughters, two granddaughters, two brothers, and a sister.